<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="potential antiviral agent carriers. For instance, antiviral drugs such as" exact="ribavirin" post="and isoprinosine have been chemically linked on a single-walled"/>
 <result pre="animals in lethal models of endotoxemia. The selective delivery of" exact="adenosine" post="and antioxidants together could serve as an innovative method"/>
 <result pre="of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with" exact="amantadine" post="through ROS-mediated AKT signaling pathwaysInt. J. Nanomed.201813200510.2147/IJN.S155994 32.LiY.LinZ.GuoM.XiaY.ZhaoM.WangC.XuT.ChenT.ZhuB.Inhibitory activity"/>
 <result pre="enhanced drug deliverySci. Adv.20195eaax078010.1126/sciadv.aax078031453334 36.Ã–ztÃ¼rkA.A.KÄ±rÄ±mlÄ±oÄŸluG.Y.Preparation and in vitro of characterization" exact="lamivudine" post="loaded nanoparticles prepared by acid or ester terminated PLGA"/>
 <result pre="antiretroviral therapyJ. Res. Pharm.201923897913 37.VenkateshD.N.BaskaranM.KarriV.V.S.R.MannemalaS.S.RadhakrishnaK.GotiS.Fabrication and in vivo evaluation of" exact="Nelfinavir" post="loaded PLGA nanoparticles for enhancing oral bioavailability and therapeutic"/>
 <result pre="oral bioavailability and therapeutic effectSaudi Pharm. J.20152366767410.1016/j.jsps.2015.02.02126702262 38.ShahL.K.AmijiM.M.Intracellular delivery of" exact="saquinavir" post="in biodegradable polymeric nanoparticles for HIV/AIDSPharm. Res.2006232638264510.1007/s11095-006-9101-716969696 39.TangX.LiangY.LiuX.ZhouS.LiuL.ZhangF.XieC.CaiS.WeiJ.ZhuY.PLGA-PEG nanoparticles"/>
 <result pre="nodes and blood in primatesAIDS Res. Hum. Retrovir.20153110711410.1089/aid.2014.021025402233 45.DuanJ.FreelingJ.P.KoehnJ.ShuC.HoR.J.Y.Evaluation of" exact="atazanavir" post="and darunavir interactions with lipids for developing pH-responsive anti-HIV"/>
 <result pre="Drug DeliverySpringerBerlin, Germany201138 114.ChiappettaD.A.FacorroG.de CelisE.R.SosnikA.Synergistic encapsulation of the anti-HIV agent" exact="efavirenz" post="within mixed poloxamine/poloxamer polymeric micellesNanomed. Nanotechnol. Biol. Med.2011762463710.1016/j.nano.2011.01.017 115.Santos-MartinezM.J.RahmeK.CorbalanJ.J.FaulknerC.HolmesJ.D.TajberL.MedinaC.RadomskiM.W.Pegylation"/>
 <result pre="for therapeutic applicationsNat. Rev. Drug Discov.2010961562710.1038/nrd259120616808 140.MaurerP.JenningsG.T.WillersJ.RohnerF.LindmanY.RoubicekK.RennerW.A.MÃ¼llerP.BachmannM.F.A therapeutic vaccine for" exact="nicotine" post="dependence: Preclinical efficacy, and Phase I safety and immunogenicityEur."/>
 <result pre="less cytotoxic (~90%) than free AgNPs (65%) or AM (56%)" exact="Amantadine" post="(AM) H1N1 [30] Selenium (Se) Uniformly spherical Se@AM (70"/>
 <result pre="antiviral activity towards the NP drugs than the free drugs" exact="Diphyllin" post="&amp;amp; Bafilomycin [33] PLGA Uniform, spherical/smooth surface NPs (116âˆ’143"/>
 <result pre="interaction between polymer and LAM confirmed by FTIR and DSC" exact="Lamivudine" post="(LAM) HIV [36] PLGA Spherical/smooth surface NFV NPs (~185"/>
 <result pre="PLGA Spherical/smooth surface NFV NPs (~185 nm); almost narrow distribution" exact="Efavirenz" post="(EFV) [37] PEO-PCL Spherical PEO-PCL NPs (~200âˆ’270 nm)with smooth"/>
 <result pre="NPs (~200âˆ’270 nm)with smooth surface; SQV is encapsulated into NPs" exact="Saquinavir" post="(SQV) [38] PLGA-PEG Spherical shape (~125 nm) for those"/>
 <result pre="loaded with SAHA; ~118 nm for NPs loaded with NFV" exact="Suberoylanilide hydroxamic acid" post="(SAHA) and NFV [39] Hybrid NPs (PLGA, PLA, MMA-SPM,"/>
 <result pre="DNA Electrochemical 0.4 pM, 1.0 nMâˆ’5.0 pM 20 Spherical, 3" exact="Daunorubicin" post="Scanometric 10 pM, 10 pMâˆ’100 nM 20 Spherical, 1.4"/>
</results>
